Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Sales (2022 - 2025)

Historic Return on Sales for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 11.46%.

  • Addex Therapeutics' Return on Sales fell 114100.0% to 11.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.46%, marking a year-over-year decrease of 179200.0%. This contributed to the annual value of 29.61% for FY2024, which is 346000.0% up from last year.
  • As of Q3 2025, Addex Therapeutics' Return on Sales stood at 11.46%, which was down 114100.0% from 20.2% recorded in Q2 2025.
  • In the past 5 years, Addex Therapeutics' Return on Sales ranged from a high of 124.66% in Q2 2024 and a low of 52.5% during Q4 2023
  • Its 4-year average for Return on Sales is 4.87%, with a median of 10.07% in 2024.
  • As far as peak fluctuations go, Addex Therapeutics' Return on Sales soared by 1280700bps in 2024, and later tumbled by -1448600bps in 2025.
  • Quarter analysis of 4 years shows Addex Therapeutics' Return on Sales stood at 10.72% in 2022, then crashed by -590bps to 52.5% in 2023, then skyrocketed by 80bps to 10.55% in 2024, then dropped by -9bps to 11.46% in 2025.
  • Its Return on Sales stands at 11.46% for Q3 2025, versus 20.2% for Q2 2025 and 16.33% for Q1 2025.